⚖ Compare news

Put up to three stories side by side. Pick IDs from any article URL: /compare?id=123&id=456

Kort efter regnskab gjorde topchefen det klart. Trods fremgang vakler Leo Pharmas børsplaner

berlingske.dk ·Denmark · culture
Words
34
Chars
236
AI summary
Yes
Full story

Leo Pharma is postponing its plans for a stock market listing despite reporting a solid financial account. The company head stated the reasons for this delay are external to the firm. He remains confident in the current strategy, which remains relevant regardless of the listing status.

Trods et solidt regnskab udskyder Leo Pharma sin børsnotering. Årsagen skal findes uden for medicinalselskabet, anfører topchefen, som understreger sin tro på strategien. En strategi, som dog har betydning, hvis selskabet går på børsen.

Open article